1,393 results on '"Panteghini, Mauro"'
Search Results
52. Definition and application of performance specifications for measurement uncertainty of 23 common laboratory tests: linking theory to daily practice
53. Role and responsibilities of laboratory medicine specialists in the verification of metrological traceability of in vitro medical diagnostics
54. Pursuing appropriateness of laboratory tests: a 15-year experience in an academic medical institution
55. Differences between Educational and Regulatory External Quality Assurance/Proficiency Testing Schemes
56. Alignment of the new generation of Abbott Alinity γ-glutamyltransferase assay to the IFCC reference measurement system should be improved
57. The simple reproducibility of a measurement result does not equal its overall measurement uncertainty
58. Harmonization Status of Serum Ferritin Measurements and Implications for Use as Marker of Iron-Related Disorders
59. ‘Penelope test’: a practical instrument for checking appropriateness of laboratory tests
60. Reply to Westgard et al.: ‘Keep your eyes wide … as the present now will later be past’*
61. More about the random uncertainty of photometric determination of hemolysis index on the Abbott Alinity c platform
62. Reply to: Hyperuricemia does not seem to be an independent risk factor for coronary heart disease
63. In reply to: Limitations in using the EFLM WG-A/ISO approach for assessment of reagent lot variability.
64. Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference
65. Fast track protocols using highly sensitive troponin assays for ruling out and ruling in non-ST elevation acute coronary syndrome
66. Evaluation of long-term imprecision of automated complete blood cell count on the Sysmex XN-9000 system
67. Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group “Laboratory Error and Patient Safety” and EFLM Task and Finish Group “Performance specifications for the extra-analytical phases”
68. Redesigning the surveillance of in vitro diagnostic medical devices and of medical laboratory performance by quality control in the traceability era.
69. Cardiac Natriuretic Hormones as Markers of Cardiovascular Disease: Methodological Aspects
70. Biological variation of serum cholinesterase catalytic concentrations
71. Improving D-dimer testing appropriateness by controlling periodicity of retesting: prevention is better than cure
72. Standardization of Cardiac Markers
73. Estimation of the reference interval for serum folate measured with assays traceable to the WHO International Standard
74. Tackling serum folate test in European countries within the health technology assessment paradigm: request appropriateness, assays and health outcomes
75. Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories
76. Progress and impact of enzyme measurement standardization
77. Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department
78. Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference
79. Definition and application of performance specifications for measurement uncertainty of 23 common laboratory tests: linking theory to daily practice.
80. Diagnostic value of transferrin
81. Biologic variability of C-reactive protein: Is the available information reliable?
82. Inside ST-elevation myocardial infarction by monitoring concentrations of cardiovascular risk biomarkers in blood
83. Definition of the Immune Parameters Related to COVID-19 Severity
84. An approach for determining allowable between reagent lot variation
85. Interpreting EQA—Understanding Why Commutability of Materials Matters
86. γ‐Glutamyltransferase reference intervals in detail
87. A step towards optimal efficiency of HbA1c measurement as a first-line laboratory test: the TOP-HOLE (Towards OPtimal glycoHemOgLobin tEsting) project
88. Myosin Light and Heavy Chains
89. Troponin I: Structure, Physiology and It’s Role in Risk Stratification of Angina Patients
90. Developments in reference measurement systems for C-reactive protein and the importance of maintaining currently used clinical decision-making criteria.
91. Revaluation of biological variation of glycated hemoglobin (HbA1c) using an accurately designed protocol and an assay traceable to the IFCC reference system
92. Improving the laboratory result release process in the light of ISO 15189:2012 standard
93. Reply to La Gioia: effects of cold agglutinins on the automated complete blood count accuracy
94. Anti-tumour necrosis factor α antibodies and circulating lymphocyte phenotypes in inflammatory bowel disease
95. Lipase elevation in serum of COVID-19 patients: frequency, extent of increase and clinical value
96. Aspartate aminotransferase in COVID‐19: A probably overrated marker
97. Are blood ammonia concentrations dependent on γ-glutamyl-transferase levels in plasma?
98. Heparinate but not serum tubes are susceptible to hemolysis by pneumatic tube transportation
99. Laboratory medicine in the new healthcare environment
100. More on the accuracy of the Architect enzymatic assay for hemoglobin A1c and its traceability to the IFCC reference system
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.